Skip to main
ARDT

ARDT Stock Forecast & Price Target

ARDT Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 42%
Hold 25%
Sell 8%
Strong Sell 0%

Bulls say

Ardent Health is a healthcare provider that operates in growing mid-sized urban markets across six states. The company has a strong focus on people and investments in services and technologies. They have strategies in place to manage risks such as dependence on government reimbursement programs and potential decreases in coverage. Management has a positive outlook on future growth, aiming for mid-teens EBITDA margins over the next several years, and has plans for outpatient expansion in 2026.

Bears say

Ardent Health is facing several challenges in its business, including a decrease in subsidies and potential losses in HIX enrollment, increased pressures in professional fee expenses and denied claims, and a high dependence on government reimbursement programs. In addition, the company's financials have been negatively impacted by one-time charges and expenses, leading to lower guidance and reduced growth expectations. All of these factors contribute to a negative outlook on Ardent Health's stock, despite its strong market presence and investment in technology and services.

ARDT has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 42% recommend Buy, 25% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ardent Health Partners LLC and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ardent Health Partners LLC (ARDT) Forecast

Analysts have given ARDT a Buy based on their latest research and market trends.

According to 12 analysts, ARDT has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ardent Health Partners LLC (ARDT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.